Bezlotoxumab - Merck & Co
At a glance
- Drug Originator Medarex; University of Massachusetts Medical School
- Drug Licenced by Merck & Co; Merck Sharp & Dohme
- Drug Class Antidiarrhoeals; Monoclonal antibodies
- Mechanism of Action Clostridium difficile toxB protein inhibitors
- USA Patent Applicants MERCK SHARP DOHME
- USA Patents 5
- BLAs 1
- International Patents 20

Disclaimer